Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Barrett Esophagus 4Breast Neoplasms 3Pancreatic Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Inflammation 2Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Obesity 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Hodgkin Disease 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colorectal Neoplasia 1Chemotherapy Effect 1Breast Neoplasms, Male 1

Interventions

peppermint oil 1bismuth tripotassium dicitrate 1S 1 (combination) 1Palliative Care 1Oxaliplatin 1Omeprazole 1Clarithromycin 1Aromatherapy 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chemotherapy Effect × Omeprazole × Clear all
NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡